2018 FSN Member Reception
Tell a Friend About This EventTell a Friend
2018 FSN Member Reception

When: Saturday, March 17, 2018
5:00 PM
Where: Hilton Lake Buena Vista Hotel
1751 Hotel Plaza Boulevard
Crystal Ballroom
Lake Buena Vista, Florida  32830
United States

Online registration is closed.
« Go to Upcoming Event List  

Florida Society of Nephrology Member Reception

FSN Members are invited to join us for a reception in the Crystal Ballroom at the Hilton Lake Buena Vista Hotel on Saturday, March 17th from 5-7 pm. Enjoy drinks and appetizers with your fellow FSN Members before heading out for your dinner plans.

Hilton Lake Buena Vista Hotel, 1751 Hotel Plaza Blvd. Lake Buena Vista, Florida  32830

FSN Members: Please click here to RSVP for the reception.

Reception Sponsors


Alexion developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG).


OPKO Health, Inc.

OPKO Renal is a division of OPKO Health, focused on developing proprietary products to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD) and vitamin D insufficiency. Our pharmaceutical business features Rayaldee™, a treatment for secondary hyperparathyroidism in stage 3-4 chronic kidney disease patients with vitamin D deficiency.


Retrophin is a biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.


Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

Veloxis is an international specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.